Because most BRCA1 cases of breast cancer are ER- and most BRCA2 cases are ER+ [15], the frequency of ER+ tumors among the overall BRCA breast cancer patients depends on the relative contribution of the gBRCA2 incidence in unselected breast cancer patients. This evidence concerns the gene BRCA2 and breast cancer.